Phosphagenics, Nestlé Nutrition’s Phospha E trial updates
Dated: 14 February 2008
Phosphagenics Limited and Nestlé Nutrition has announced that their joint phase 2 human clinical trial to establish the efficacy of Phosphagenics’ Phospha E in the management of metabolic syndrome is advancing at three sites in Adelaide, Australia.
Based on current recruitment rates of study participants, the double-blind phase 2 trial, which is fully funded by Nestlé, is expected to be completed in mid-2008.
This phase 2 clinical trial follows two pre-clinical dose response trials completed by Nestlé and Phosphagenics in 2006.
The results of those studies confirmed that, when given orally, Phospha E significantly reduces many of the key biomarkers associated with metabolic syndrome.
Metabolic syndrome is characterised by a group of risk factors that increase the risk of diabetes, coronary heart disease and other diseases associated with plaque build up in artery walls.
The companies have agreed the principal terms of a commercialisation agreement, which will grant a worldwide exclusive license to Nestlé for the use of Phospha E in medical foods and for Phosphagenics to be the exclusive manufacturer and supplier of Phospha E to Nestlé.
The final commercial agreement is due to be signed on completion of the phase 2 trial.
(18 August 2008) Purveyor of antibiotic and hormone free meats and cheeses Applegate Farms has launched the Applegate Farms Yogurt Cheese with probiotics in the US. The new pre-sliced cheese is a m...
(10 July 2008) China-Biotics, Inc. says Shuguang Fang, Chief Technology Officer of the probiotics company, will be a guest speaker at China's 3rd Annual Food Safety Technology Forum 2008. Organiz...
(1 May 2008) Weak joints now have a new help. Gelita, the gelatine and collagen hydrolysate giant, has launched a new therapeutic agent that can counter the effects of the degenerative joint di...
(22 February 2008) Barentz Europe BV has announced the acquisition of a major stake in Vitablend Holding, a privately held production company of antioxidants, vitamin and mineral blends and nutraceut...
(8 October 2007) Danish company Novozymes A/S said it has completed the acquisition of the enzyme activities of Biocon Limited in Bangalore, India. Biocon’s activities will be integrated into Novoz...
(5 October 2007) Packaging supplier, Tetra Pak, will be involved in three new school feeding programmes by the end of 2007, in addition to those started in Vietnam and Pakistan earlier this year. T...
(5 October 2007) Wrigley's ability to provide oral health benefits have earned Wrigley’s Orbit, Extra and Eclipse sugar-free chewing gums the American Dental Association’s (ADA) Seal of Acceptance....
(13 September 2007) The lack of vitamin D early in pregnancy can increase the risk of developing pre-eclampsia by five folds, according to a study from the University of Pittsburgh Schools of the Heal...
Chains such as Safeway, Whole Foods Markets and Wal-Mart, are pushing solar panel installation projects to gain a 30% tax credit. Kathy Loftus from Whole Foods Market, commented: "We're hoping that our purchases along with some other retailers will help bring the technology costs."
After X5 announced that all new hypermarkets will be opened under the Karusel brand, Russia's largest food retailer, gained 3.2% in London trading. The retailer aims to add as much as 160,000 sq m of space this year as economic growth in Russia enables more people to buy higher-priced foods and shop in stores rather than at open markets.
Wal-Mart has announced plans to invest around USD 1 billion in Brazil and open 80 to 90 new stores, in all its formats, in 2009. It will be the largest investment the retailer has made in Brazil since it opened its first operation in Sao Paulo in 1995.
Although sales are up by 17% for Fresh & Wild Ltd, the UK unit of Whole Foods Market, the company has reported ₤7 million loss for the year to September 30, 2007. Some analysts feel that there is too much working against Whole Foods for it to really get off the ground.
Carrefour has been keeping its entry into Iran low-key, as both the retailer and Tehran's government suspect that the foreign presence may cause some excitement. It is not clear yet how feasible it will be for Carrefour to maintain supply in the face of financial restrictions on trade with Iran as a result of US sanctions.
The sale of 107 Somerfield stores, purchased last month by the Co-operative Group, is being handled by Credit Suisse which has requested that potential bidders offer up proposals before 22 August.
